Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- CRN Applauds Confirmation Of Dr. Crawford As New FDA Commissioner
The Council for Responsible Nutrition (CRN), issued a statement in response to the confirmation of Lester Crawford, D.V.M., Ph.D., to the post of Food and Drug Administration (FDA) Commissioner.
- CRN Applauds Confirmation Of Dr. Crawford As New FDA Commissioner
The Council for Responsible Nutrition (CRN), issued a statement in response to the confirmation of Lester Crawford, D.V.M., Ph.D., to the post of Food and Drug Administration (FDA) Commissioner.
- Increased Demand For Astaxanthin to be Met By Fuji Health Science, Inc.
Company announces that it has successfully completed a New Dietary Ingredient (NDI) notification to the FDA under DSHEA for AstaREAL® astaxanthin produced at its facility in Gustavsberg, Sweden.
- Increased Demand For Astaxanthin to be Met By Fuji Health Science, Inc.
Company announces that it has successfully completed a New Dietary Ingredient (NDI) notification to the FDA under DSHEA for AstaREAL® astaxanthin produced at its facility in Gustavsberg, Sweden.
- Increased Demand For Astaxanthin to be Met By Fuji Health Science, Inc.
Company announces that it has successfully completed a New Dietary Ingredient (NDI) notification to the FDA under DSHEA for AstaREAL® astaxanthin produced at its facility in Gustavsberg, Sweden.
- Increased Demand For Astaxanthin to be Met By Fuji Health Science, Inc.
Company announces that it has successfully completed a New Dietary Ingredient (NDI) notification to the FDA under DSHEA for AstaREAL® astaxanthin produced at its facility in Gustavsberg, Sweden.
- Increased Demand For Astaxanthin to be Met By Fuji Health Science, Inc.
Company announces that it has successfully completed a New Dietary Ingredient (NDI) notification to the FDA under DSHEA for AstaREAL® astaxanthin produced at its facility in Gustavsberg, Sweden.
- Increased Demand For Astaxanthin to be Met By Fuji Health Science, Inc.
Company announces that it has successfully completed a New Dietary Ingredient (NDI) notification to the FDA under DSHEA for AstaREAL® astaxanthin produced at its facility in Gustavsberg, Sweden.
- Increased Demand For Astaxanthin to be Met By Fuji Health Science, Inc.
Company announces that it has successfully completed a New Dietary Ingredient (NDI) notification to the FDA under DSHEA for AstaREAL® astaxanthin produced at its facility in Gustavsberg, Sweden.
- Increased Demand For Astaxanthin to be Met By Fuji Health Science, Inc.
Company announces that it has successfully completed a New Dietary Ingredient (NDI) notification to the FDA under DSHEA for AstaREAL® astaxanthin produced at its facility in Gustavsberg, Sweden.
- AHPA Posts Revised Facts about Codex / EU Directive / CAFTA
document, “Codex Alimentarius and dietary supplements,” has now been revised to provide information on the current status of the European Union’s Directive on Vitamin and Mineral Supplements and to address emerging concerns related to CAFTA.
- AHPA Posts Revised Facts about Codex / EU Directive / CAFTA
document, “Codex Alimentarius and dietary supplements,” has now been revised to provide information on the current status of the European Union’s Directive on Vitamin and Mineral Supplements and to address emerging concerns related to CAFTA.
- AHPA Posts Revised Facts about Codex / EU Directive / CAFTA
document, “Codex Alimentarius and dietary supplements,” has now been revised to provide information on the current status of the European Union’s Directive on Vitamin and Mineral Supplements and to address emerging concerns related to CAFTA.
- AHPA Posts Revised Facts about Codex / EU Directive / CAFTA
document, “Codex Alimentarius and dietary supplements,” has now been revised to provide information on the current status of the European Union’s Directive on Vitamin and Mineral Supplements and to address emerging concerns related to CAFTA.
- NNFA Update: Echinacea Study Questioned/CAFTA Passed, Still No Threat
Association notes NEJM article on echinacea and questions dose used; observes that CAFTA passes with no impact on DSHEA's governing of the industry.
- NNFA Update: Echinacea Study Questioned/CAFTA Passed, Still No Threat
Association notes NEJM article on echinacea and questions dose used; observes that CAFTA passes with no impact on DSHEA's governing of the industry.
- NNFA Update: Echinacea Study Questioned/CAFTA Passed, Still No Threat
Association notes NEJM article on echinacea and questions dose used; observes that CAFTA passes with no impact on DSHEA's governing of the industry.
- NNFA Update: Echinacea Study Questioned/CAFTA Passed, Still No Threat
Association notes NEJM article on echinacea and questions dose used; observes that CAFTA passes with no impact on DSHEA's governing of the industry.
- NNFA Update: Echinacea Study Questioned/CAFTA Passed, Still No Threat
Association notes NEJM article on echinacea and questions dose used; observes that CAFTA passes with no impact on DSHEA's governing of the industry.
- NNFA Update: Echinacea Study Questioned/CAFTA Passed, Still No Threat
Association notes NEJM article on echinacea and questions dose used; observes that CAFTA passes with no impact on DSHEA's governing of the industry.
- Nutrition 21 Receives Widespread Approval in Europe for the Continued Sale of Chromax(R) Chromium Picolinate and Zinmax(R) Zinc Picolinate
Company has received "derogation" in more than 17 member states within the European Union (EU) for Chromax(R) chromium picolinate and Zinmax(R) zinc picolinate as ingredients and stand-alone brands.
- Nutrition 21 Receives Widespread Approval in Europe for the Continued Sale of Chromax(R) Chromium Picolinate and Zinmax(R) Zinc Picolinate
Company has received "derogation" in more than 17 member states within the European Union (EU) for Chromax(R) chromium picolinate and Zinmax(R) zinc picolinate as ingredients and stand-alone brands.
- Nutrition 21 Receives Widespread Approval in Europe for the Continued Sale of Chromax(R) Chromium Picolinate and Zinmax(R) Zinc Picolinate
Company has received "derogation" in more than 17 member states within the European Union (EU) for Chromax(R) chromium picolinate and Zinmax(R) zinc picolinate as ingredients and stand-alone brands.
- Nutrition 21 Receives Widespread Approval in Europe for the Continued Sale of Chromax(R) Chromium Picolinate and Zinmax(R) Zinc Picolinate
Company has received "derogation" in more than 17 member states within the European Union (EU) for Chromax(R) chromium picolinate and Zinmax(R) zinc picolinate as ingredients and stand-alone brands.
- Nutrition 21 Receives Widespread Approval in Europe for the Continued Sale of Chromax(R) Chromium Picolinate and Zinmax(R) Zinc Picolinate
Company has received "derogation" in more than 17 member states within the European Union (EU) for Chromax(R) chromium picolinate and Zinmax(R) zinc picolinate as ingredients and stand-alone brands.
- Nutrition 21 Receives Widespread Approval in Europe for the Continued Sale of Chromax(R) Chromium Picolinate and Zinmax(R) Zinc Picolinate
Company has received "derogation" in more than 17 member states within the European Union (EU) for Chromax(R) chromium picolinate and Zinmax(R) zinc picolinate as ingredients and stand-alone brands.
- Nutrition 21 Receives Widespread Approval in Europe for the Continued Sale of Chromax(R) Chromium Picolinate and Zinmax(R) Zinc Picolinate
Company has received "derogation" in more than 17 member states within the European Union (EU) for Chromax(R) chromium picolinate and Zinmax(R) zinc picolinate as ingredients and stand-alone brands.
- FSANZ seeks Public Comment on Proposed Changes to the Food Code
Agency invites comment on several proposals including Phytosterols in fruit juice and fruit juice drinks, and fortification of cereal-based beverages.
- FSANZ seeks Public Comment on Proposed Changes to the Food Code
Agency invites comment on several proposals including Phytosterols in fruit juice and fruit juice drinks, and fortification of cereal-based beverages.
- FSANZ seeks Public Comment on Proposed Changes to the Food Code
Agency invites comment on several proposals including Phytosterols in fruit juice and fruit juice drinks, and fortification of cereal-based beverages.
- FSANZ seeks Public Comment on Proposed Changes to the Food Code
Agency invites comment on several proposals including Phytosterols in fruit juice and fruit juice drinks, and fortification of cereal-based beverages.
- CRN Supports "Food Stamp" Bill
Associations, urges committee members to give strong consideration to a bill introduced last week by Senators Tom Harkin (D-Iowa) and Orrin Hatch (R-Utah), that would provide low-income households the opportunity to use their food stamps to purchase vitamin and mineral supplements.
- CRN Supports "Food Stamp" Bill
Associations, urges committee members to give strong consideration to a bill introduced last week by Senators Tom Harkin (D-Iowa) and Orrin Hatch (R-Utah), that would provide low-income households the opportunity to use their food stamps to purchase vitamin and mineral supplements.
- CRN Supports "Food Stamp" Bill
Associations, urges committee members to give strong consideration to a bill introduced last week by Senators Tom Harkin (D-Iowa) and Orrin Hatch (R-Utah), that would provide low-income households the opportunity to use their food stamps to purchase vitamin and mineral supplements.
- CRN Supports "Food Stamp" Bill
Associations, urges committee members to give strong consideration to a bill introduced last week by Senators Tom Harkin (D-Iowa) and Orrin Hatch (R-Utah), that would provide low-income households the opportunity to use their food stamps to purchase vitamin and mineral supplements.
- Food & Drug Administration approves LycoMato® as safe color additive
FDA is amending its color additive regulations to provide for the safe use of LycoMato® tomato lycopene extract as a color additive in foods, in response to a Color Additive Petition filed by LycoRed Natural Products Industries.
- Food & Drug Administration approves LycoMato® as safe color additive
FDA is amending its color additive regulations to provide for the safe use of LycoMato® tomato lycopene extract as a color additive in foods, in response to a Color Additive Petition filed by LycoRed Natural Products Industries.
- Food & Drug Administration approves LycoMato® as safe color additive
FDA is amending its color additive regulations to provide for the safe use of LycoMato® tomato lycopene extract as a color additive in foods, in response to a Color Additive Petition filed by LycoRed Natural Products Industries.
- Food & Drug Administration approves LycoMato® as safe color additive
FDA is amending its color additive regulations to provide for the safe use of LycoMato® tomato lycopene extract as a color additive in foods, in response to a Color Additive Petition filed by LycoRed Natural Products Industries.
- Food & Drug Administration approves LycoMato® as safe color additive
FDA is amending its color additive regulations to provide for the safe use of LycoMato® tomato lycopene extract as a color additive in foods, in response to a Color Additive Petition filed by LycoRed Natural Products Industries.
- Effective Date of AHPA Trade Recommendations Nears
Recommendations include: appropriate steps be taken to assure that black cohosh rhizome and root raw material is free of its known adulterant, Chinese cimicifuga rhizome and root, and dislosure of caffeine on product labels.
- Effective Date of AHPA Trade Recommendations Nears
Recommendations include: appropriate steps be taken to assure that black cohosh rhizome and root raw material is free of its known adulterant, Chinese cimicifuga rhizome and root, and dislosure of caffeine on product labels.
- Effective Date of AHPA Trade Recommendations Nears
Recommendations include: appropriate steps be taken to assure that black cohosh rhizome and root raw material is free of its known adulterant, Chinese cimicifuga rhizome and root, and dislosure of caffeine on product labels.
- Effective Date of AHPA Trade Recommendations Nears
Recommendations include: appropriate steps be taken to assure that black cohosh rhizome and root raw material is free of its known adulterant, Chinese cimicifuga rhizome and root, and dislosure of caffeine on product labels.
- AHPA Tele-Seminar to Help Companies Understand How FDA Inspections Should be Conducted and Managed
Tele-seminars are scheduled to begin at 2 pm ET / 11 am PT on August 30 and September 8, 2005; each seminar will be limited to just 30 call lines.
- AHPA Tele-Seminar to Help Companies Understand How FDA Inspections Should be Conducted and Managed
Tele-seminars are scheduled to begin at 2 pm ET / 11 am PT on August 30 and September 8, 2005; each seminar will be limited to just 30 call lines.
- FDA Review Period Extended for Nutrition 21's Chromium Picolinate Diabetes-Related Qualified Health Claim Petition
Company agrees to fDA's request to extend review period for two weeks.
- FDA Review Period Extended for Nutrition 21's Chromium Picolinate Diabetes-Related Qualified Health Claim Petition
Company agrees to fDA's request to extend review period for two weeks.
- FDA Approves First Qualified Health Claim for Chromium Picolinate and Risk of Type 2 Diabetes
FDA has concluded that there is credible evidence to support the following qualified health claim: “One small study suggests that chromium picolinate may reduce the risk of insulin resistance, and therefore possibly may reduce the risk of type 2 diabetes. FDA concludes, however, that the existence of such a relationship between chromium picolinate and either insulin resistance or type 2 diabetes is highly uncertain.”
- FDA Approves First Qualified Health Claim for Chromium Picolinate and Risk of Type 2 Diabetes
FDA has concluded that there is credible evidence to support the following qualified health claim: “One small study suggests that chromium picolinate may reduce the risk of insulin resistance, and therefore possibly may reduce the risk of type 2 diabetes. FDA concludes, however, that the existence of such a relationship between chromium picolinate and either insulin resistance or type 2 diabetes is highly uncertain.”
- FDA Approves First Qualified Health Claim for Chromium Picolinate and Risk of Type 2 Diabetes
FDA has concluded that there is credible evidence to support the following qualified health claim: “One small study suggests that chromium picolinate may reduce the risk of insulin resistance, and therefore possibly may reduce the risk of type 2 diabetes. FDA concludes, however, that the existence of such a relationship between chromium picolinate and either insulin resistance or type 2 diabetes is highly uncertain.”
- FDA Approves First Qualified Health Claim for Chromium Picolinate and Risk of Type 2 Diabetes
FDA has concluded that there is credible evidence to support the following qualified health claim: “One small study suggests that chromium picolinate may reduce the risk of insulin resistance, and therefore possibly may reduce the risk of type 2 diabetes. FDA concludes, however, that the existence of such a relationship between chromium picolinate and either insulin resistance or type 2 diabetes is highly uncertain.”
- FDA Publishes Guidance for Bioterrorism Recordkeeping Requirements
FDA announced the publication of a guidance document on the recordkeeping requirements of the Bioterrorism Act; the guidance topics include who must comply with and who is excluded from the rule, and what information is required to be kept and made available to FDA during a Bioterrorism investigation.
- FDA Publishes Guidance for Bioterrorism Recordkeeping Requirements
FDA announced the publication of a guidance document on the recordkeeping requirements of the Bioterrorism Act; the guidance topics include who must comply with and who is excluded from the rule, and what information is required to be kept and made available to FDA during a Bioterrorism investigation.
- NSF International to Host Training Seminar on Good Manufacturing Practices
To help manufacturers interpret the new guidelines, NSF International will be hosting a GMP seminar on October 14, 2005 at the Sheraton Atlantic City Convention Center Hotel in Atlantic City, NJ.
- NSF International to Host Training Seminar on Good Manufacturing Practices
To help manufacturers interpret the new guidelines, NSF International will be hosting a GMP seminar on October 14, 2005 at the Sheraton Atlantic City Convention Center Hotel in Atlantic City, NJ.
- NSF International to Host Training Seminar on Good Manufacturing Practices
To help manufacturers interpret the new guidelines, NSF International will be hosting a GMP seminar on October 14, 2005 at the Sheraton Atlantic City Convention Center Hotel in Atlantic City, NJ.
- NSF International to Host Training Seminar on Good Manufacturing Practices
To help manufacturers interpret the new guidelines, NSF International will be hosting a GMP seminar on October 14, 2005 at the Sheraton Atlantic City Convention Center Hotel in Atlantic City, NJ.
- NSF International to Host Training Seminar on Good Manufacturing Practices
To help manufacturers interpret the new guidelines, NSF International will be hosting a GMP seminar on October 14, 2005 at the Sheraton Atlantic City Convention Center Hotel in Atlantic City, NJ.
- New AHPA FDA Inspection Guidance Available
AHPA’s Guidance for Addressing FDA Inspections of Dietary Supplement Facilities is now available for purchase from AHPA’s online bookstore (http://www.ahpa.org/bookstore.htm).
- New AHPA FDA Inspection Guidance Available
AHPA’s Guidance for Addressing FDA Inspections of Dietary Supplement Facilities is now available for purchase from AHPA’s online bookstore (http://www.ahpa.org/bookstore.htm).
- Three Cortislim Defendants to Give up $4.5 Million in Cash and Other Assets
California-based Pinnacle Marketing Concepts, Inc. and its president, Thomas F. Cheng, and Shawn M. Talbott will give up $4.5 million in cash and other assets to settle Federal Trade Commission charges stemming from their roles in the marketing of CortiSlim and CortiStress; FTC’s litigation continues against four remaining defendants.
- Three Cortislim Defendants to Give up $4.5 Million in Cash and Other Assets
California-based Pinnacle Marketing Concepts, Inc. and its president, Thomas F. Cheng, and Shawn M. Talbott will give up $4.5 million in cash and other assets to settle Federal Trade Commission charges stemming from their roles in the marketing of CortiSlim and CortiStress; FTC’s litigation continues against four remaining defendants.
- Three Cortislim Defendants to Give up $4.5 Million in Cash and Other Assets
California-based Pinnacle Marketing Concepts, Inc. and its president, Thomas F. Cheng, and Shawn M. Talbott will give up $4.5 million in cash and other assets to settle Federal Trade Commission charges stemming from their roles in the marketing of CortiSlim and CortiStress; FTC’s litigation continues against four remaining defendants.
- FDA Commissioner Lester Crawford Resigns
US Food and Drug Administration Commissioner Lester Crawford has announced his resignation effective immediately.
- FDA Commissioner Lester Crawford Resigns
US Food and Drug Administration Commissioner Lester Crawford has announced his resignation effective immediately.
- FDA Commissioner Lester Crawford Resigns
US Food and Drug Administration Commissioner Lester Crawford has announced his resignation effective immediately.
- FDA Commissioner Lester Crawford Resigns
US Food and Drug Administration Commissioner Lester Crawford has announced his resignation effective immediately.
- FDA Commissioner Lester Crawford Resigns
US Food and Drug Administration Commissioner Lester Crawford has announced his resignation effective immediately.
- AHPA Files Further Comments with FDA on NDI Process
Organization's position is that in the case of an unprocessed herb or botanical, a single complete NDI notification is sufficient, but with semi-purified extracts of botanicals, the end product might be significantly different. "“Each manufacturer of such extracts should submit an NDI notification with the requisite safety information.”
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Schaffhausen, Switzerland – Merck Eprova AG announced today that Metafolin, its new patented form of folate, has been approved as a safe alternative to folic acid for use in dietary supplements, foods for special dietary uses and other foods by the Joint FAO/WHO Expert Committee on Food Additives (JECFA).
Metafolin (the calcium salt of L-5-methyltetrahydrofolic acid or, for short, L-methylfolate) belongs to the group of folate vitamins (Vitamin B9, Folacin) which the human body must obtain from dietary sources.
At present, folic acid is typically used in dietary supplements and vitamin-enriched foods as a source of folate. However, not being a natural form of folate, folic acid must first be assimilated by the human body before it can exert its vitamin function. In contrast, Merck Eprova AG’s Metafolin can directly be used by the body without further metabolic transformation.
JECFA concluded at its latest meeting in Geneva on July 13, 2005, that there are no safety concerns with the proposed use of dry crystalline or microencapsulated Metafolin in dietary supplements and vitamin enriched foods.
Continued…
The JECFA approval of Metafolin comes after the US Food and Drug Administration (FDA) notification in 2001 and the positive evaluation by European Food Safety Authority (EFSA) in October 2004. A positive evaluation by JECFA is an important first step for securing further approvals in many other countries around the World.
According to Martin Ulmann, General Manager of Merck Eprova AG, the JECFA report opens the door to making Metafolin a global product. “Metafolin is a product of several years of careful research. We are delighted that we will soon be able to offer the benefits of Metafolin to customers around the world. Now more consumers will have access to the natural form of this essential nutrient which is important for maintaining good health."
"Food is the major dietary source for folates. However, in large part of the population folate intake with food is well below the Recommended Dietary Allowance (RDA). An insufficient intake of folates is associated with an increased risk for many disorders including anaemia, neural tube defects, various forms of cardiovascular diseases, Alzheimer's disease, colon cancer and depression," commented Dr. Rudolf Moser, Scientific Director of Merck Eprova AG.
Metafolin has been used in a wide range of dietary supplements and medical foods in the U.S. since 2001. During 2005, Merck Eprova is preparing the launch of the ingredient into EU markets. “Metafolin is body-ready and is the only folate able to cross the blood brain barrier,” explained Roger Weibel, Product Manager of Merck Eprova AG. “Given a choice, we believe many health-conscious consumers will choose Metafolin as the preferred source of folate.”
Merck Eprova AG is a wholly-owned subsidiary of Merck KGaA of Darmstadt, Germany, and is the largest producer of specialty folates for oral and parenteral pharmaceutical applications and dietary supplements. Located in Schaffhausen, Switzerland, the company is a centre of excellence for research, development, production and marketing of pure and stable forms of folate derivatives.
Contact: Roger Weibel
Phone: ++41 [52] 630 7332
E-mail: roger.weibel@eprova.com
http://www.eprova.com
http://www.metafolin.com |